Abstract:OBJECTIVE:To analyze the differences of clinical manifestations and laboratory features between primary Sjögren's syndrome (pSS) patients with positive and negative anti-Sjögren's syndrome type B (SSB) antibody.METHODS:The clinical data of pSS patients hospitalized in Department of Rheumato-logy and Immunology, Peking University Third Hospital were retrospectively analyzed to investigate the differences of clinical and laboratory features between anti-SSB positive and negative groups. The t test, Mann-Whitney U test, Chi-square test and Fisher's exact probability were used for analysis.RESULTS:A total of 142 pSS patients were enrolled in this study, including 137 females and 5 males with a mean age of (54.8±13.3) years. The anti-SSB positive group included 44 patients accounting for 31.0% of the pSS patients. The anti-SSB positive pSS patients were younger at disease onset and at visit [age at visit: (50.9±14.5) years vs. (56.5±12.4) years; age at onset: (42.2±14.8) years vs. (49.5±15.3) years, P < 0.05]. The patients with anti-SSB positive more frequently presented with rash (29.5% vs. 14.3%, P < 0.05), enlargement of parotid glands (27.3% vs. 8.2%, P < 0.05), renal tubular acidosis (15.9% vs. 4.2%, P < 0.05), immune thrombocytopenia (9.1% vs. 1.0%, P < 0.05), rheumatoid factor (RF) positive (85.0% vs. 49.4%, P < 0.05), higher RF and antinuclear antibody (ANA) titers (median: 89.8 IU/mL vs. 20.5 IU/mL; median: 320 vs. 160, P < 0.05), anti-Sjögren's syndrome type A (SSA) antibody positive (97.7% vs. 64.3%, P < 0.05), elevation of γ globulin (71.4% vs. 38.5%, P < 0.05), higher levels of IgG (median: 21.0 g/L vs. 15.6 g/L, P < 0.05), higher proportions of CD3-CD19+ cells [(21.0±11.9)% vs. (13.7±9.6)%, P < 0.05] and lower proportions of CD3+ cells [(67.2±14.4)% vs. (76.6%±13.1)%, P < 0.05] than those negative. However, the anti-SSB positive group was less likely to show anti-mitochondrial antibodies (AMA)-M2 positivity (10.5% vs. 35.6%, P < 0.05). Glucocorticoids (90.9% vs. 73.5%, P < 0.05) and immunosuppressants (54.5% vs. 36.7%, P < 0.05) were more frequently used in anti-SSB positive pSS patients than those negative.CONCLUSION:The anti-SSB positive pSS patients were younger at disease onset while more frequently presenting with various symptoms, higher levels of other antibodies and activation of B cells than those negative. Glucocorticoids and immunosuppressants were more frequently used, indicating that anti-SSB positive group presented with a more severe clinal phenotype.

Comparisons of Clinical Characteristics of Primary Sj(o)gren's Syndrome Onset at Different Ages

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Clinical and Serological Features of Younger Onset Primary Sj?gren’s Syndrome:a Comparison with Elderly Onset Disease

Clinical Profiles of Patients with Primary Sjgren's Syndrome with Different Age of Onset in China

[Analysis of the Clinical Features at Onset of Primary Sjögren's Syndrome].

The clinical characteristics of 573 cases of primary Sj(o)gren's syndrome

Patients with Early-Onset Primary Sjögren’s Syndrome Have Distinctive Clinical Manifestations and Circulating Lymphocyte Profiles

Clinical Features of Primary Sjogren Syndrome in Youth

[Comparison of Clinical and Immunological Characteristics Between Primary Sjögren's Syndrome Patients with Positive and Negative Anti-Ssb Antibody].

Clinical Features of Primary Sjogren's Syndrome in Younger Patients

Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients with Primary Sjogren's Syndrome

Clinical Characteristics and Outcome of Elderly Onset Adult-Onset Still?s Disease: A 10-Year Retrospective Study

Clinical features of newly-diagnosed primary Sj(o)gren's syndrome: analysis of 86 cases

Clinical and Laboratory Characteristics of Sjgren's Syndrome that Progressed to Systemic Lupus Erythematosus

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development

Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development

Childhood-onset primary Sjögren's syndrome in a tertiary center in China: Clinical features and outcome

Childhood-onset Primary Sjögren’s Syndrome in a Tertiary Center in China: Clinical Features and Outcome

Clinical Features of Primary Sjǒgren's Syndrome Involved in the Extra-Gland Organs As Initial Manifestations

Clinical Features of Primary Sj(o)gren's Syndrome Associated Lung Involvement in Patients with Extra-Glandular Manifestations at Disease Onset

Clinical analysis of the neurological involvement in primary Sj(o)gren's syndrome